Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients

NCT02686710 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Glycogen Synthase Kinase 3

Interventions

DRUG: Sevoflurane
DRUG: Propofol

Sponsor

Moscow Regional Research and Clinical Institute (MONIKI)